Consistent with these observations the rate of Bcl-xL deamidation was found to be significantly reduced in hepatocellular carcinomas compared to normal liver tissue and this has been linked to a resistance of the transformed cells to undergo apoptosis [17]. The gene discussed is BCL2L1; the disease is hepatocellular carcinoma.